Market Eyes LiveMcKesson Corporation (MCK) Stock Rating & Analysis
MELANY's data-driven read on McKesson Corporation · Wholesale-Drugs, Proprietaries & Druggists' Sundries.
McKesson is one of three leading US pharmaceutical wholesalers, sourcing and distributing branded, generic, and specialty pharmaceuticals to pharmacies (retail chains, independents, and mail order), hospital networks, and healthcare providers. Together with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US, McKesson conducts pharmaceutical wholesale and distribution in Canada.
Why MCK scores 52/100
MELANY scores McKesson Corporation 52/100 by weighing eight factors. Here is how MCK breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- FCF yield 6.8%
Margins, returns on capital, and balance-sheet strength.
Direction and relative strength of the recent share-price trend.
- Price +4.7% above 50-day MA
History of beating or missing estimates, and where estimates are heading.
- Beat EPS estimates 4 of last 4 quarters
What Wall Street price targets and revisions are signalling.
Near-term events that could move the stock.
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
Key risks for MCK
- No specific company-level red flags detected, monitor macro regime changes
Sector and theme context
McKesson Corporation sits in the Healthcare sector theme, which MELANY currently rates 46/100 for strength. Theme strength feeds MCK's momentum and catalyst factors above.
Tracking MCK
McKesson Corporation rates Hold right now, so MELANY is not flagging a fresh entry. Create a free account to add MCK to your watchlist and get alerted the moment the rating changes.
How MELANY rates MCK
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. McKesson Corporation's 52/100 reflects mature factor weighting for its profile.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about MCK
Is McKesson Corporation (MCK) a buy?
As of 2026-08-21, MELANY rated McKesson Corporation Hold with a composite score of 52/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is McKesson Corporation's MELANY score?
McKesson Corporation (MCK) has a MELANY composite score of 52/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, and macro fit.
How is the MCK stock rating calculated?
MELANY scores MCK from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy McKesson Corporation stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates McKesson Corporation (MCK) Hold with a composite of 52/100 as of 2026-08-21. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the MCK stock price forecast?
MELANY does not publish price targets or forecasts for MCK. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 52/100 across eight factors for McKesson Corporation, and re-scores automatically as new price, earnings, and fundamental data arrive.
Is MCK stock overvalued or undervalued?
MELANY's valuation factor currently reads 57/100 for McKesson Corporation, where a higher score means the price looks more attractive against earnings, growth, and peers. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives MCK's read.
What price should I buy MCK at?
MELANY is not flagging a fresh entry for MCK at its current Hold rating, so there is no entry zone to publish right now. Watchlisting MCK in the free app gets you alerted the moment that changes.
What are the risks of buying MCK stock?
The top risks MELANY currently flags for McKesson Corporation: No specific company-level red flags detected, monitor macro regime changes. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is McKesson Corporation a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 8/100 for McKesson Corporation, and earnings track record, at 76/100. The 52/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will MCK stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 53/100 for MCK right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this MCK rating?
The rating on this page is a snapshot of MELANY's read as of 2026-08-21. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores MCK continuously as new price, earnings, and fundamental data arrive, and that current rating is free in the app.
MCK's live rating and alerts are free either way. The app is our flagship.